Suppression of the HPA axis during cholestasis can be attributed to hypothalamic bile acid signaling

Molecular Endocrinology

Volumn 29, Issue 12, 2015, Pages 1720-1730

  McMillin, Matthew ^a,b   Frampton, Gabriel ^a,b   Quinn, Matthew ^c   Divan, Ali ^b   Grant, Stephanie ^a,b   Patel, Nisha ^a   Newell Rogers, Karen ^b   DeMorrow, Sharon ^a,b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APICAL SODIUM DEPENDENT BILE ACID TRANSPORTER; BILE ACID; CARRIER PROTEIN; COLESTYRAMINE; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID RECEPTOR; GLYCOCHENODEOXYCHOLIC ACID; MESSENGER RNA; NEUROPEPTIDE; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE ACID BLOOD LEVEL; BLOOD BRAIN BARRIER; CHOLESTASIS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; HORMONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BILE ACIDS AND SALTS; CHOLESTYRAMINE RESIN; CORTICOTROPIN-RELEASING HORMONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; MALE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84948963519     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2015-1087     Document Type: Article

References (42)

1. Jacobson L. Hypothalamic-pituitary-adrenocortical axis regulation. Endocrinol Metab Clin North Am. 2005;34:271-292, vii.
2. Leonard BE. HPA and immune axes in stress: involvement of the serotonergic system. Neuroimmunomodulation. 2006;13:268-276.
3. Koslo RJ, Gmerek DE, Cowan A, Porreca F. Intrathecal bombesin-induced inhibition of gastrointestinal transit: requirement for an intact pituitary-adrenal axis. Regul Pept. 1986;14:237-242.
4. Solomon S. POMC-derived peptides and their biological action. Ann NY Acad Sci. 1999;885:22-40.
5. Jones MT, Hillhouse EW, Burden JL. Dynamics and mechanics of corticosteroid feedback at the hypothalamus and anterior pituitary gland. J Endocrinol. 1977;73:405-417.
6. Quinn M, Ueno Y, Pae HY, et al. Suppression of the HPA axis during extrahepatic biliary obstruction induces cholangiocyte proliferation in the rat. Am J Physiol Gastrointest Liver Physiol. 2012; 302:G182-G193.
7. Swain MG, Maric M. Defective corticotropin-releasing hormone mediated neuroendocrine and behavioral responses in cholestatic rats: implications for cholestatic liver disease-related sickness behaviors. Hepatology. 1995;22:1560-1564.
8. Swain MG, Patchev V, Vergalla J, Chrousos G, Jones EA. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. J Clin Invest. 1993;91:1903-1908.
9. Williams RD, Elliott DW, Zollinger RM. The effect of hypotension in obstructive jaundice. Arch Surg. 1960;81:334-340.
10. Zollinger RM, Williams RD. Surgical aspects of jaundice. Surgery. 1956;39:1016-1030.
11. Binder G, Martin DD, Kanther I, Schwarze CP, Ranke MB. The course of neonatal cholestasis in congenital combined pituitary hormone deficiency. J Pediatr Endocrinol Metab. 2007;20:695-702.
12. Gö EN, Kandemir N, Andiran N, Ozön A, Yordam N. Cholestatic hepatitis as a result of severe cortisol deficiency in early infancy: report of two cases and review of literature. Turk J Pediatr. 2006;48:376-379.
13. Karnsakul W, Sawathiparnich P, Nimkarn S, Likitmaskul S, San-tiprabhob J, Aanpreung P. Anterior pituitary hormone effects on hepatic functions in infants with congenital hypopituitarism. Ann Hepatol. 2007;6:97-103.
14. Harry R, Auzinger G, Wendon J. The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology. 2002;36: 395-402.
15. Tsai MH, Peng YS, Chen YC, et al. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology. 2006; 43:673-681.
16. Fernández J, Escorsell A, Zabalza M, et al. Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival. Hepatology. 2006;44:1288-1295.
17. St-Pierre MV, Kullak-Ublick GA, Hagenbuch B, Meier PJ. Transport of bile acids in hepatic and non-hepatic tissues. J Exp Biol. 2001;204:1673-1686.
18. Dawson PA. Role of the intestinal bile acid transporters in bile acid and drug disposition. Handb Exp Pharmacol. 2011:169-203.
19. Redinger RN. The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: bile salts as ligands for nuclear hormone receptors. Can J Gastroenterol. 2003;17:265-271.
20. Zhou H, Hylemon PB. Bile acids are nutrient signaling hormones. Steroids. 2014;86:62-68.
21. Miura T, Ouchida R, Yoshikawa N, et al. Functional modulation of the glucocorticoid receptor and suppression of NF-KB-dependent transcription by ursodeoxycholic acid. J Biol Chem. 2001;276: 47371-47378.
22. Hofmann AF. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med. 1999;159:2647-2658.
23. Greim H, Trülzsch D, Czygan P, et al. Mechanism of cholestasis. 6. Bile acids in human livers with or without biliary obstruction. Gastroenterology. 1972;63:846-850.
24. Greim H, Trülzsch D, Roboz J, et al. Mechanism of cholestasis. 5. Bile acids in normal rat livers and in those after bile duct ligation. Gastroenterology. 1972;63:837-845.
25. Muriel P, Castro V. Dose-response studies of interferon-a 2b on liver fibrosis and cholestasis induced by biliary obstruction in rats. Pharmacology. 1997;54:179-185.
26. Raiford DS. Pruritus of chronic cholestasis. QJM. 1995;88:603-607.
27. Ma Z, Lee SS, Meddings JB. Effects of altered cardiac membrane fluidity on ß-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy. J Hepatol. 1997;26:904-912.
28. Bomzon A, Ljubuncic P. Bile acids as endogenous vasodilators? Biochem Pharmacol. 1995;49:581-589.
29. Quinn M, McMillin M, Galindo C, Frampton G, Pae HY, DeMorrow S. Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms. Dig Liver Dis. 2014;46:527-534.
30. Shneider BL, Dawson PA, Christie DM, Hardikar W, Wong MH, Suchy FJ. Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter. J Clin Invest. 1995;95:745-754.
31. Dickmeis T. Glucocorticoids and the circadian clock. J Endocrinol. 2009;200:3-22.
32. McMillin M, Frampton G, Tobin R, et al. TGR5 signaling reduces neuroinflammation during hepatic encephalopathy. J Neurochem. 2015; doi:10.1111/jnc.13243.
33. McMillin M, Galindo C, Pae HY, et al. Gli1 activation and protection against hepatic encephalopathy is suppressed by circulating transforming growth factor ß1 in mice. J Hepatol. 2014;61:1260-1266.
34. DeMorrow S, Francis H, Gaudio E, et al. The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. Am J Physiol Gastroin-test Liver Physiol. 2008;295:G1150-G1158.
35. DeMorrow S, Glaser S, Francis H, et al. Opposing actions of endo-cannabinoids on cholangiocarcinoma growth: recruitment of fas and fas ligand to lipid rafts. J Biol Chem. 2007;282:13098-13113.
36. DeMorrow S, Francis H, Gaudio E, et al. Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thiore-doxin 1/redox factor 1 and AP-1 activation. Am J Physiol Gastro-intest Liver Physiol. 2008;294:G506-G519.
37. Mills CO, Rahman K, Coleman R, Elias E. Cholyl-lysylfluorescein: synthesis, biliary excretion in vivo and during single-pass perfusion of isolated perfused rat liver. Biochim Biophys Acta. 1991;1115: 151-156.
38. de Waart DR, Häusler S, Vlaming ML, et al. Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein. J Pharmacol Exp Ther. 2010;334:78-86.
39. McNeilly AD, Macfarlane DP, O’Flaherty E, et al. Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice. J Hepatol. 2010;52:705-711.
40. Swain MG, Maric M, Carter L. Defective interleukin-1-induced ACTH release in cholestatic rats: impaired hypothalamic PGE2 release. Am J Physiol. 1995;268:G404-G409.
41. Ashfaq S, McMillin M, Galindo C, Frampton G, DeMorrow S. Elevated serum bile acids contribute to the neurological impairment following acute liver failure. Gastroenterology. 2014;146:S953-S954.
42. Williams G, Harrold JA, Cutler DJ. The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box. Proc Nutr Soc. 2000;59:385-396.